Download FREE Report Sample
Download Free sampleBiomarkers are a class of markers related to cell growth and proliferation that have been proposed in recent years with the development of immunology and molecular biology techniques. Biomarkers can not only discuss the pathogenesis at the molecular level, but also have a unique advantage in accurately and sensitively evaluating early and low-level damage. They can provide early warning, which largely provides clinicians with auxiliary diagnosis Basis.
Clinical Biomarkers Market contains market size and forecasts of Clinical Biomarkers in Global, including the following market information:
Global Clinical Biomarkers Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Clinical Biomarkers market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diagnostic Biomarkers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Clinical Biomarkers include Abbott Laboratories, Agilent Technologies, Inc., ALCEDIAG, Becton, Dickinson and Company, bioM?rieux S.A., Bio-Rad Laboratories, Inc., CENTOGENE N.V., F. Hoffmann-La Roche Ltd. and Enzo Biochem Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Clinical Biomarkers companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clinical Biomarkers Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Clinical Biomarkers Market Segment Percentages, by Type, 2021 (%)
Diagnostic Biomarkers
Predictive Biomarkers
Prognostic Biomarkers
Global Clinical Biomarkers Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Clinical Biomarkers Market Segment Percentages, by Application, 2021 (%)
Research and Academic Laboratories
Biopharmaceutical and Biotech Companies
Diagnostic Centers
Others
Global Clinical Biomarkers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Clinical Biomarkers Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Clinical Biomarkers revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Clinical Biomarkers revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Agilent Technologies, Inc.
ALCEDIAG
Becton, Dickinson and Company
bioM?rieux S.A.
Bio-Rad Laboratories, Inc.
CENTOGENE N.V.
F. Hoffmann-La Roche Ltd.
Enzo Biochem Inc.
Illumina, Inc.
Myriad Genetics, Inc.
Quest Diagnostics Incorporated
QIAGEN N.V.
Thermo Fisher Scientific Inc.
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy